Publication | Closed Access
H107, a new aminoglycoside anti-Pseudomonas antibiotic produced by a new strain of Spirillospora.
32
Citations
0
References
2000
Year
Spirillospora SppAntimicrobial SusceptibilityHealth SciencesAntibioticsPseudomonas Spp.Strain 719MedicineBacteriologyAntimicrobial ChemotherapyMicrobiologyAntimicrobial CompoundNew StrainClinical MicrobiologyAntimicrobial ResistanceDrug Resistance
Spirillospora spp. (strain 719) has been the source of several antibiotics. One of these designated H107 is produced as a trace. Compared with other antibiotics produced by the same strain, it was obtained only from the broth filtrate after precipitation with acetic acid followed by extraction with n-butanol. It was a water soluble metabolite active against Gram-negative bacteria and especially Pseudomonas spp., and was identified as an aminoglycoside compound. This is the first report of aminoglycoside anti-Pseudomonas production by Spirillospora.